Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd. (NYSE:BHVN) announced that it has started a research collaboration with Bexorg, Inc. targeting central nervous system disorders.
Bexorg, which is a techbio company, has a platform that can revive and study whole human and pig brains using artificial blood. This technology helps them see how drugs affect actual brain tissue. The platform produces deep data about how genes and proteins behave in disease and health.
A pharmacist in a white coat with a range of drugs on shelves behind her.
Both companies will use this technology to help design and test new therapies for CNS conditions. As a result of this collaboration, two Biohaven Ltd. preclinical programs will benefit from these unique brain studies. Bexorg’s approach offers a big leap ahead of normal lab models.
Biohaven Ltd. is a biopharmaceutical company that develops and commercializes treatments for diseases in immunology, neuroscience, and oncology.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
